Other Assets, Noncurrent in USD of IGC Pharma, Inc. from Q1 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
IGC Pharma, Inc. quarterly Other Assets, Noncurrent history and change rate from Q1 2011 to Q3 2025.
  • IGC Pharma, Inc. Other Assets, Noncurrent for the quarter ending 30 Sep 2025 was $672K, a 2.18% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

IGC Pharma, Inc. Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $672K -$15K -2.18% 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 $680K -$8K -1.16% 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $681K -$7K -1.02% 31 Mar 2025 10-Q 14 Nov 2025
Q4 2024 $681K -$318K -31.8% 31 Dec 2024 10-Q 14 Feb 2025
Q3 2024 $687K -$311K -31.2% 30 Sep 2024 10-Q 12 Nov 2024
Q2 2024 $688K -$329K -32.4% 30 Jun 2024 10-Q 07 Aug 2024
Q1 2024 $688K -$315K -31.4% 31 Mar 2024 10-K 27 Jun 2025
Q4 2023 $999K -$29K -2.82% 31 Dec 2023 10-Q 14 Feb 2024
Q3 2023 $998K +$48K +5.05% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $1.02M +$95K +10.3% 30 Jun 2023 10-Q 10 Aug 2023
Q1 2023 $1M +$66K +7.04% 31 Mar 2023 10-K 24 Jun 2024
Q4 2022 $1.03M +$416K +68% 31 Dec 2022 10-Q 14 Feb 2023
Q3 2022 $950K +$339K +55.5% 30 Sep 2022 10-Q 01 Nov 2022
Q2 2022 $922K +$326K +54.7% 30 Jun 2022 10-Q 05 Aug 2022
Q1 2022 $937K +$334K +55.4% 31 Mar 2022 10-K 07 Jul 2023
Q4 2021 $612K -$7K -1.13% 31 Dec 2021 10-Q 10 Feb 2022
Q3 2021 $611K -$5K -0.81% 30 Sep 2021 10-Q 29 Oct 2021
Q2 2021 $596K -$10K -1.65% 30 Jun 2021 10-Q 11 Aug 2021
Q1 2021 $603K -$7K -1.15% 31 Mar 2021 10-K 23 Jun 2022
Q4 2020 $619K -$249K -28.7% 31 Dec 2020 10-Q 16 Feb 2021
Q3 2020 $616K -$251K -29% 30 Sep 2020 10-Q 20 Nov 2020
Q2 2020 $606K -$289K -32.3% 30 Jun 2020 10-Q 19 Aug 2020
Q1 2020 $610K -$268K -30.5% 31 Mar 2020 10-K 14 Jun 2021
Q4 2019 $868K +$81K +10.3% 31 Dec 2019 10-Q 10 Feb 2020
Q3 2019 $867K +$48K +5.86% 30 Sep 2019 10-Q 06 Nov 2019
Q2 2019 $895K +$435K +94.4% 30 Jun 2019 10-Q 09 Aug 2019
Q1 2019 $878K +$394K +81.4% 31 Mar 2019 10-K 13 Jul 2020
Q4 2018 $787K -$33.9K -4.13% 31 Dec 2018 10-Q 12 Feb 2019
Q3 2018 $819K +$127K +18.4% 30 Sep 2018 10-Q 16 Oct 2018
Q2 2018 $460K -$212K -31.5% 30 Jun 2018 10-Q 03 Aug 2018
Q1 2018 $484K -$55.7K -10.3% 31 Mar 2018 10-K 14 Jun 2019
Q4 2017 $821K +$330K +67.2% 31 Dec 2017 10-Q 20 Feb 2018
Q3 2017 $692K +$188K +37.2% 30 Sep 2017 10-Q 17 Nov 2017
Q2 2017 $672K +$175K +35.1% 30 Jun 2017 10-Q 18 Aug 2017
Q1 2017 $540K +$32.4K +6.39% 31 Mar 2017 10-K 21 Jun 2018
Q4 2016 $491K +$80.8K +19.7% 31 Dec 2016 10-Q 21 Feb 2017
Q3 2016 $504K +$89.6K +21.6% 30 Sep 2016 10-Q 21 Nov 2016
Q2 2016 $498K +$70.7K +16.6% 30 Jun 2016 10-Q 16 Aug 2016
Q1 2016 $507K +$73K +16.8% 31 Mar 2016 10-K 14 Jul 2017
Q4 2015 $410K -$24.2K -5.57% 31 Dec 2015 10-Q 16 Feb 2016
Q3 2015 $414K -$31.5K -7.07% 30 Sep 2015 10-Q 13 Nov 2015
Q2 2015 $427K -$32.9K -7.15% 30 Jun 2015 10-Q 14 Aug 2015
Q1 2015 $434K -$24.3K -5.3% 31 Mar 2015 10-K 14 Jul 2016
Q4 2014 $434K +$34K +8.5% 31 Dec 2014 10-Q 12 Feb 2015
Q3 2014 $446K +$49.9K +12.6% 30 Sep 2014 10-Q 13 Nov 2014
Q2 2014 $460K +$32.9K +7.7% 30 Jun 2014 10-Q 14 Aug 2014
Q1 2014 $459K -$7.53K -1.62% 31 Mar 2014 10-K 14 Jul 2015
Q4 2013 $400K -$577K -59% 31 Dec 2013 10-Q 14 Feb 2014
Q3 2013 $396K -$651K -62.2% 30 Sep 2013 10-Q 08 Nov 2013
Q2 2013 $427K -$567K -57% 30 Jun 2013 10-Q 16 Aug 2013
Q1 2013 $466K -$533K -53.3% 31 Mar 2013 10-K 15 Jul 2014
Q4 2012 $977K +$731K +296% 31 Dec 2012 10-Q 13 Feb 2013
Q3 2012 $1.05M +$902K +619% 30 Sep 2012 10-Q 14 Nov 2012
Q2 2012 $994K +$702K +241% 30 Jun 2012 10-Q/A 21 Aug 2012
Q1 2012 $999K +$250K +33.4% 31 Mar 2012 10-K 15 Jul 2014
Q4 2011 $247K 31 Dec 2011 10-Q 16 Feb 2012
Q3 2011 $146K 30 Sep 2011 10-Q 18 Nov 2011
Q2 2011 $292K 30 Jun 2011 10-Q 18 Aug 2011
Q1 2011 $749K 31 Mar 2011 10-K 16 Jul 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.